Alterna Wealth Management, Inc Gilead Sciences, Inc. Transaction History

Alterna Wealth Management, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $845,581 - $959,750	-13,033 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $86,787 - $98,890	-1,532 Reduced 10.52%	13,033 $759,000
Q3 2020 Oct 19, 2020	SELL	$62.1 - $78.08 $50,611 - $63,635	-815 Reduced 5.3%	14,565 $920,000
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $79,574 - $92,400	-1,100 Reduced 6.67%	15,380 $1.18 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $302,377 - $387,302	-4,828 Reduced 22.66%	16,480 $1.23 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $30,810 - $33,890	-500 Reduced 2.29%	21,308 $1.39 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $193,843 - $213,969	-3,101 Reduced 12.45%	21,808 $1.38 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.51 Million - $1.7 Million	-24,431 Reduced 49.52%	24,909 $1.68 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $88,479 - $99,120	1,415 Added 2.95%	49,340 $3.21 Million
Q4 2018 Mar 04, 2019	BUY	$60.54 - $79.0 $2.34 Million - $3.06 Million	38,683 Added 418.56%	47,925 $3 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $559,510 - $730,118	9,242 New	9,242 $654,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Alterna Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Alterna Wealth Management, Inc with notifications on news.